MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Whole exome trio analysis in isolated population of southeast Moravia (Czech Republic) with familial parkinsonism suggests its heterogeneous genetic background

    K. Menšíková, R. Vodička, K. Kolaříková, R. Vrtěl, J. Štellmachová, T. Bartoníková, M. Procházka, P. Kaňovský (Olomouc, Czech Republic)

    Objective: The aim of the study was to identify shared genetic variants potentially associated with familial neurodegenerative parkinsonism using whole-exome analysis. Background: Increased prevalence of…
  • MDS Virtual Congress 2020

    Genome-wide association studies of progression in Parkinson’s disease

    M. Tan, M. Shoai, M. Lawton, S. Kanavou, N. Wood, J. Hardy, Y. Ben-Shlomo, N. Williams, M. Hu, D. Grosset, H. Morris (London, United Kingdom)

    Objective: To identify genetic variants associated with composite (cross-domain), motor, and cognitive progression in Parkinson’s disease (PD). Background: Case-control genome-wide association studies (GWASs) in PD…
  • MDS Virtual Congress 2020

    Male-specific exacerbation of susceptibility to α-synuclein pre-formed fibrils by developmental dieldrin exposure in mice

    A. Gezer, J. Kochmanski, S. VanOeveren, A. Cole-Strauss, C. Kemp, J. Patterson, K. Miller, N. Kuhn, D. Herman, A. McIntire, J. Lipton, K. Luk, S. Fleming, C. Sortwell, A. Bernstein (Grand Rapids, MI, USA)

    Objective: To determine whether developmental exposure to dieldrin exacerbates susceptibility to α-synuclein (α-syn) preformed fibril (PFF)-induced synucleinopathy in adulthood. Background: Parkinson’s disease (PD) is characterized…
  • MDS Virtual Congress 2020

    Feasibility of Studying the PD Microbiome in Frozen Saliva and Formalin-Fixed Colon From the Systemic Synuclein Sampling Study (S4)

    S. Mosovsky, B. Methe, T. Beach, C. Adler, C. Coffey, T. Foroud, J. Eberling, B. Mollenhauer, L. Chahine (Pittsburgh, PA, USA)

    Objective: To examine feasibility of obtaining microbiome data from frozen saliva and formalin-fixed, paraffin-embedded (FFPE) colon specimens. Background: The gastrointestinal tract microbiome is of great…
  • MDS Virtual Congress 2020

    Cancerous inhibitor of protein phosphatase 2A in Parkinson’s disease

    S.J Yin, C. Han, T. Wang (Wuhan, China)

    Objective: To investigate the expression level of Cancerous Inhibitor of Protein phosphatase 2A (CIP2A) in Parkinson’s disease (PD), and explore the relationship between CIP2A and…
  • MDS Virtual Congress 2020

    Increased availability of the metabotropic glutamate receptor 5 in the motor system of patients with Parkinson’s disease

    C.J Doppler, E. Farrher, C. Régio Brambilla, C.P Filss, J. Lindemeyer, A. Gogishvili, B. Neumaier, M.T Barbe, I. Neuner, C. Lerche, N.J Shah, K.J Langen, G.R Fink, M. Sommerauer (Jülich, Germany)

    Objective: To investigate glutamatergic signaling in Parkinson’s disease (PD) compared to age- and gender-matched healthy controls by using 11C-ABP688-PET combined with MRI. Background: Increasing evidence…
  • MDS Virtual Congress 2020

    Noradrenergic terminal and locus coeruleus cell loss may be uncoupled in Parkinson’s disease – a PET and MRI multi-modal imaging study

    M. Kinnerup, C. Doppler, E. Farrher, T. Fedorova, J. Schaldemose, K. Knudsen, R. Isamail, A. Hansen, K. Stær, G. Fink, J. Shah, D. Brooks, A. Nahimi, P. Borghammer, M. Sommerauer (Aarhus, Denmark)

    Objective: To assess multimodal imaging of the noradrenergic system: magnetic resonance imaging (MRI) neuromelanin contrast of the locus coeruleus (LC) and noradrenalin transporter density with…
  • MDS Virtual Congress 2020

    Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson’s disease

    G. Pagano, S. Molloy, P. Bain, E. Rabiner, K. Chaudhuri, D. Brooks, N. Pavese (Basel, Switzerland)

    Objective: To investigate the relationship between ventral striatum D3 dopamine receptor availability and severity of impulse control disorder (ICD) in Parkinson’s disease (PD). Background: Reduced…
  • MDS Virtual Congress 2020

    Association Between Ventricle/Brain Volumes and Mobility Metrics in Parkinson’s Disease

    A. Ragothaman, A. Giritharan, M. Mancini, O. Miranda-Dominguez, D. Fair, J. Nutt, F. Horak (Portland, OR, USA)

    Objective: To investigate the relationship between brain ventricular and gray matter volumes and objective balance and gait metrics in people with Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2020

    Microglial activation associated with a faster progression of nigrostriatal dysfunction in patients with isolated REM sleep behavior disorder

    K. Stær, A. Iranzo, M. Stokholm, K. Østergaard, M. Serradell, M. Otto, K. Svendsen, A. Pla, D. Vilas, J. Santamaria, A. Møller, C. Gaig, D. Brooks, P. Borghammer, E. Tolosa, N. Pavese (Aarhus N, Denmark)

    Objective: To assess the role of early microglial activation on the progression of nigrostriatal dysfunction, measured with 18F-DOPA PET, in isolated REM sleep behavior disorder…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley